Clinical Trials Logo

Torticollis clinical trials

View clinical trials related to Torticollis.

Filter by:

NCT ID: NCT02131467 Completed - Cervical Dystonia Clinical Trials

Safety and Tolerability of Perampanel in Cervical Dystonia

SAFE-PER-CD
Start date: September 1, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

Cervical dystonia (CD) is the most common focal dystonia. Currently there are no effective oral medications for the treatment of CD. While botulinum toxin injections improve symptoms, they require repeated injections by a trained physician and some patients stop responding to injections or never respond at all. Therefore, alternative treatment options for CD are needed. One new agent is a drug that targets glutamate receptors that are thought to be involved dystonia. This drug, perampanel, was originally developed for epilepsy and is licensed for use in the USA and Canada for treating epilepsy. The purpose of this study is to test the effectiveness of perampanel in treating the symptoms of CD.

NCT ID: NCT02069548 Completed - Cervical Dystonia Clinical Trials

Analysis of Three-dimensional Movements of the Head in Cervical Dystonia

STAC1
Start date: February 2014
Phase: N/A
Study type: Observational

This study addresses postures and range of motion in cervical dystonia (Spasmodic Torticollis). It uses 3D miniature and wireless motion captures sensors, and aims to increase the understanding of the biomechanics of the movement disorders of the cervical column in this pathology. In addition, the clinical state of cervical dystonia of the patients will be assessed, using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS). The investigators will compare the results between control and study groups.

NCT ID: NCT02046447 Completed - Clinical trials for Primary Cervical Dystonia

Neuroimaging of Dystonia

NID
Start date: May 2014
Phase: N/A
Study type: Observational

The main purpose of this study is to investigate primary cervical dystonia as compared to healthy control subjects and DYT 1 dystonia as compared to healthy control subjects by examining cognitive measures, physical measures, and structural and functional magnetic resonance imaging (MRI). The secondary aim of this study is to investigate a specific drug therapy for primary cervical dystonia to develop a functional MRI (fMRI) research paradigm. The drug, trihexyphenidyl, is FDA approved to treat Parkinson's Disease and is commonly prescribed by physicians as a treatment for symptoms of primary cervical dystonia.

NCT ID: NCT01860196 Completed - Clinical trials for Adult Cerebral Palsy

Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy

ATHETOID_CD
Start date: June 2013
Phase: Phase 4
Study type: Interventional

This study aimed to compare the efficacy and safety of Meditoxin® injection for cervical dystonia in adults with cerebral palsy. It is a placebo controlled, Cross-over, Double blind, Randomized, Clinical trial.

NCT ID: NCT01859247 Completed - Cervical Dystonia Clinical Trials

Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study

Start date: March 2013
Phase: N/A
Study type: Interventional

The overall objective of this application is to therapeutically target the dysfunctional premotor-motor interaction in dystonia—and to provide a focused treatment of specific anatomical networks in order to reduce side effects and to improve symptom control over conventional therapies.

NCT ID: NCT01840462 Completed - Cervical Dystonia Clinical Trials

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]

CDNISLongterm
Start date: July 2012
Phase:
Study type: Observational

The objective of this study is to investigate the efficacy of Dysport® in the treatment of cervical dystonia (CD) in a non-interventional long-term study in naïve and pre-treated patients.

NCT ID: NCT01753349 Completed - Cervical Dystonia Clinical Trials

Phase IV-Cervical Dystonia-INTEREST IN CD2

INTEREST_INCD2
Start date: December 2012
Phase:
Study type: Observational

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

NCT ID: NCT01753336 Completed - Cervical Dystonia Clinical Trials

Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia

Start date: March 2013
Phase: Phase 3
Study type: Interventional

The purpose of the protocol is to assess the long term safety of repeat treatment cycles of Dysport® 500 U using 2 mL dilution scheme for the treatment of Cervical Dystonia. This is an extension study to study A-TL-52120-169 (hereafter referred to as Study 169).

NCT ID: NCT01753310 Completed - Cervical Dystonia Clinical Trials

Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia.

Start date: January 2013
Phase: Phase 3
Study type: Interventional

The purpose of the protocol is to evaluate the efficacy and safety of Dysport® using 2 mL dilution compared with placebo for the treatment of Cervical Dystonia.

NCT ID: NCT01671527 Completed - Cervical Dystonia Clinical Trials

Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia

Start date: August 2012
Phase: N/A
Study type: Observational

The purpose of this research study is to determine the physical brain changes in people with cervical dystonia after deep brain stimulation (DBS) surgery and as compared to healthy controls. We will do this by measuring your body's response to transcranial magnetic stimulation (TMS) before and/or after DBS surgery. TMS is a non-invasive procedure during which you sit in a chair that looks like one you would find at the dentist's office. A nerve stimulator is placed on the wrist of the right hand to stimulate the median nerve; the intensity of the nerve stimulator is gradually increased until the right thumb begins to twitch. A magnetic coil is placed on the scalp on one side of the head, overlying the brain's motor cortex, to stimulate the brain's output to the muscles in the opposite hand. If you are a control subject, and therefore will not/have not have DBS surgery, we will measure the body's response to TMS for comparison purposes. We expect that the electrical differences in the brain may be related to the physical benefits some patients with primary cervical dystonia receive from DBS surgery.